Development and Characterization of a High Sensitivity Segmented Fast Neutron Spectrometer (FaNS-2).

We present the development of a segmented fast neutron spectrometer (FaNS-2) based upon plastic scintillator and He proportional counters. It was designed to measure both the flux and spectrum of fast neutrons in the energy range of few MeV to 1 GeV. FaNS-2 utilizes capture-gated spectroscopy to identify neutron events and reject backgrounds.

Characterization of a 6Li-loaded liquid organic scintillator for fast neutron spectrometry and thermal neutron detection.

The characterization of a liquid scintillator incorporating an aqueous solution of enriched lithium chloride to produce a scintillator with 0.40% (6)Li is presented, including the performance of the scintillator in terms of its optical properties and neutron response. The scintillator was incorporated into a fast neutron spectrometer, and the light output spectra from 2.

Cosmic Coincidences: Investigations for Neutron Background Suppression.

Two experimental investigations were made in order to reduce background counts in neutron detectors. Each investigation relied upon the fact that neutron background is largely due to cosmic ray interactions with the air and ground. The first attempt was to look at neutron arrival times.

NIST Calibration of a Neutron Spectrometer ROSPEC.

A neutron spectrometer was acquired for use in the measurement of National Institute of Standards and Technology neutron fields. The spectrometer included options for the measurement of low and high energy neutrons, for a total measurement range from 0.01 eV up to 17 MeV.

[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].

Background And Objective: Hereditary medullary thyroid carcinoma (MTC) is caused by germline mutations of the RET proto-oncogene. A genotype - phenotype correlation has been established, showing clustering of mutations in exons 10 and 11 in classical MEN 2 A syndrome, in exon 16 codon 918 in MEN 2 B syndrome and in exons 13-15 in familial MTC. A line of evidence suggested that the development and the aggressiveness of MTC in the different cancer syndromes is variable.